Thierry Chauche
CIK: 0001895174
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Sagimet Biosciences Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 28, 2026SGMT
Sagimet Biosciences Inc.
Award(A)DirectStock Option (Right to Buy)
50K shares- - Feb 19, 2026SGMT
Sagimet Biosciences Inc.
Award(A)Direct44K shares- - Feb 10, 2026SGMT
Sagimet Biosciences Inc.
Sale(S)Direct1.3K shares at avg. $5.36$7K - Feb 6, 2025SGMT
Sagimet Biosciences Inc.
Award(A)Direct17K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 28, 2026 | SGMT Sagimet Biosciences Inc. | Award(A) Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Feb 19, 2026 | SGMT Sagimet Biosciences Inc. | Award(A) | 44,000 | - | $0 | Direct |
| Feb 10, 2026 | SGMT Sagimet Biosciences Inc. | Sale(S) | 1,312 | $5.36 | $7,033 | Direct |
| Feb 6, 2025 | SGMT Sagimet Biosciences Inc. | Award(A) | 17,000 | - | - | Direct |
1-4 of 4 transactions
About Chauche Thierry
Chauche Thierry (SEC CIK 0001895174) files insider reports with the SEC as Chief Financial Officer of Sagimet Biosciences Inc. (SGMT).
Signal8 holds 4 ownership filings by Chauche Thierry, all Form 4s, filed between Feb 7, 2025 and Jun 1, 2026. Those filings report 4 transactions, from Feb 6, 2025 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chauche Thierry's filings is in SAN MATEO, CA.
Recent filings by Chauche Thierry
Other insiders filing for Sagimet Biosciences Inc. (SGMT)
- Kemble George, Director
- Happel David, President & CEO
- Rozek Elizabeth, Chief Legal & Admin. Officer
- SEIDENBERG BETH C, Director
- Hoelscher Paul W., Director
- Jarrett Jennifer, Director